Your browser doesn't support javascript.
loading
Prevalence, predictors, and outcomes of major congenital anomalies: A population-based register study.
Al-Dewik, Nader; Samara, Muthanna; Younes, Salma; Al-Jurf, Rana; Nasrallah, Gheyath; Al-Obaidly, Sawsan; Salama, Husam; Olukade, Tawa; Hammuda, Sara; Marlow, Neil; Ismail, Mohamed; Abu Nada, Taghreed; Qoronfleh, M Walid; Thomas, Binny; Abdoh, Ghassan; Abdulrouf, Palli Valapila; Farrell, Thomas; Al Qubaisi, Mai; Al Rifai, Hilal.
Afiliação
  • Al-Dewik N; Department of Research, Women's Wellness and Research Center, Hamad Medical Corporation, P.O. Box 3050, Doha, Qatar. Naldewik@hamad.qa.
  • Samara M; Translational Research Institute (TRI), Hamad Medical Corporation (HMC), Doha, Qatar. Naldewik@hamad.qa.
  • Younes S; Genomics and Precision Medicine (GPM), College of Health and Life Science (CHLS), Hamad Bin Khalifa University (HBKU), 34110, Doha, Qatar. Naldewik@hamad.qa.
  • Al-Jurf R; Faculty of Health and Social Care Sciences, Kingston University, St. George's University of London, London, UK. Naldewik@hamad.qa.
  • Nasrallah G; Department of Pediatrics and Neonatology, Neonatal Intensive Care Unit, Newborn Screening Unit, Women's Wellness and Research Center, Hamad Medical Corporation, Doha, Qatar. Naldewik@hamad.qa.
  • Al-Obaidly S; Department of Psychology, Kingston University London, Kingston upon Thames, UK.
  • Salama H; Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, Doha, Qatar.
  • Olukade T; Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, Doha, Qatar.
  • Hammuda S; Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, Doha, Qatar.
  • Marlow N; Obstetrics and Gynecology Department, Women's Wellness and Research Center, Hamad Medical Corporation, Doha, Qatar.
  • Ismail M; Department of Pediatrics and Neonatology, Neonatal Intensive Care Unit, Newborn Screening Unit, Women's Wellness and Research Center, Hamad Medical Corporation, Doha, Qatar.
  • Abu Nada T; Department of Pediatrics and Neonatology, Neonatal Intensive Care Unit, Newborn Screening Unit, Women's Wellness and Research Center, Hamad Medical Corporation, Doha, Qatar.
  • Qoronfleh MW; Department of Psychology, Kingston University London, Kingston upon Thames, UK.
  • Thomas B; Institute for Women's Health, UCL, London, UK.
  • Abdoh G; Translational Research Institute (TRI), Hamad Medical Corporation (HMC), Doha, Qatar.
  • Abdulrouf PV; Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, Doha, Qatar.
  • Farrell T; Q3CG Research Institute, Research & Policy Division, 7227 Rachel Drive, Ypsilanti, MI, 48917, USA.
  • Al Qubaisi M; Department of Pharmacy, Women's Wellness and Research Center, Hamad Medical Corporation, Doha, Qatar.
  • Al Rifai H; Department of Pediatrics and Neonatology, Neonatal Intensive Care Unit, Newborn Screening Unit, Women's Wellness and Research Center, Hamad Medical Corporation, Doha, Qatar.
Sci Rep ; 13(1): 2198, 2023 02 07.
Article em En | MEDLINE | ID: mdl-36750603
ABSTRACT
Congenital anomalies (CAs) are a leading cause of morbidity and mortality in early life. We aimed to assess the incidence, risk factors, and outcomes of major CAs in the State of Qatar. A population-based retrospective data analysis of registry data retrieved from the Perinatal Neonatal Outcomes Research Study in the Arabian Gulf (PEARL-Peristat Study) between April 2017 and March 2018. The sample included 25,204 newborn records, which were audited between April 2017 and March 2018, of which 25,073 live births were identified and included in the study. Maternal risk factors and neonatal outcomes were assessed for association with specific CAs, including chromosomal/genetic, central nervous system (CNS), cardiovascular system (CVS), facial, renal, multiple congenital anomalies (MCAs) using univariate and multivariate analyses. The incidence of any CA among live births was 1.3% (n = 332). The most common CAs were CVS (n = 117; 35%), MCAs (n = 69, 21%), chromosomal/genetic (51; 15%), renal (n = 39; 12%), CNS (n = 20; 6%), facial (14, 4%), and other (GIT, Resp, Urogenital, Skeletal) (n = 22, 7%) anomalies. Multivariable regression analysis showed that multiple pregnancies, parity ≥ 1, maternal BMI, and demographic factors (mother's age and ethnicity, and infant's gender) were associated with various specific CAs. In-hospital mortality rate due to CAs was estimated to be 15.4%. CAs were significantly associated with high rates of caesarean deliveries (aOR 1.51; 95% CI 1.04-2.19), Apgar < 7 at 1 min (aOR 5.44; 95% CI 3.10-9.55), Apgar < 7 at 5 min (aOR 17.26; 95% CI 6.31-47.18), in-hospital mortality (aOR 76.16; 37.96-152.8), admission to neonatal intensive care unit (NICU) or perinatal death of neonate in labor room (LR)/operation theatre (OT) (aOR 34.03; 95% CI 20.51-56.46), prematurity (aOR 4.17; 95% CI 2.75-6.32), and low birth weight (aOR 5.88; 95% CI 3.92-8.82) before and after adjustment for the significant risk factors. This is the first study to assess the incidence, maternal risk factors, and neonatal outcomes associated with CAs in the state of Qatar. Therefore, a specialized congenital anomaly data registry is needed to identify risk factors and outcomes. In addition, counselling of mothers and their families may help to identify specific needs for pregnant women and their babies.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anormalidades Múltiplas / Morte Perinatal Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anormalidades Múltiplas / Morte Perinatal Idioma: En Ano de publicação: 2023 Tipo de documento: Article